Publication | Closed Access
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension
24
Citations
43
References
2021
Year
This study identifies CHK1/2 as key regulators of lung fibrosis and provides a proof of principle for CHK1/2 inhibition as a potential novel therapeutic option for IPF and IPF+PH.
| Year | Citations | |
|---|---|---|
Page 1
Page 1